Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effect of divalent metal ions on the binding of tissue factor and activated factor VII.

Thrombosis research·1997

Same author

The use of combinatorial and automated synthesis in drug discovery.

Proceedings of the Western Pharmacology Society·1997

Same author

A new combination of protecting groups and links for encoded synthetic libraries suited for consecutive tests on the solid phase and in solution.

Molecular diversity·1996

Same author

A comparative study of the brain uptake and early kinetics of 99mTc-dl HM-PAO and other PnAO derivatives in baboons.

Nuklearmedizin. Nuclear medicine·1986

Same author

Dinitrophenyl-pepstatins as active-site-directed localization reagents for cathepsin D.

The Biochemical journal·1983

Same author

Bimane: a new fluorescent label for univalent antigen-binding fragments of IgG.

Journal of immunological methods·1982

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Antibodies for neoplastic disease : solid tumors.

¹ChemOvation Ltd., Horsham, UK.

Methods in Molecular Medicine

|February 22, 2011

Summary

Therapeutic antibodies, including monoclonal and engineered fragments, offer high selectivity and affinity for targeting cancer. Decades of development have led to their use as single agents or conjugated therapies to combat malignant disease.

Area of Science:

Biotechnology
Immunology
Oncology

Background:

Antibody fragments (polyclonal, monoclonal, engineered) offer high selectivity and affinity.
These reagents show promise for influencing malignant disease growth and spread.
Therapeutic antibodies have been developed over decades.

Purpose of the Study:

To review the development and application of therapeutic antibodies.
To highlight the potential of antibody fragments in cancer treatment.
To discuss antibody conjugation strategies.

Main Methods:

Review of scientific literature on antibody development.
Analysis of antibody selectivity and affinity in therapeutic contexts.
Examination of antibody-drug conjugates and other therapeutic strategies.

More Related Videos

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

Related Experiment Videos

Last Updated: Jun 4, 2026

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

Main Results:

Engineered antibody fragments provide versatile tools for targeted therapies.
Therapeutic antibodies can be used as standalone treatments or conjugated agents.
Significant advancements have been made in antibody-based cancer treatments.

Conclusions:

Antibody fragments are valuable reagents for cancer therapy due to their specificity.
Continued development of therapeutic antibodies, including conjugated forms, holds promise for improved disease management.
The versatility of antibody engineering facilitates novel approaches to treating malignant diseases.